Inflation rebates to reduce Medicare payment for 34 Part B drugs

This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.

How will the Inflation Reduction Act affect Medicare enrollees

Another round of Part B drugs capped by inflation rebates

Potential Implications of Policy Changes in Medicaid Drug

Injecting Price Competition into Medicare Part B Drugs-Mon, 07/26

Chart: The Ever-Increasing Cost of Medicare Drugs

The Inflation Reduction Act: Implementation of the Medicare

Special Report: Inflation Reduction Act Sets Part D Stakeholders

Medicare Drug Price Negotiation Under the Inflation Reduction Act

IRA Medicare Part B Negotiation Shifts Financial Risk to

Medicare Blog, Medicare News, Medicare Information